Immunocore Holdings plc (NASDAQ:IMCR) Q2 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Immunocore conference call and webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Immunocore Holdings Plc (IMCR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,322,656 | $72,884,945 | 0.71% | |
| 2. | Tang Capital Management Kevin C. Tang | 2,105,608 | $66,073,979 | +10% | 3.34% |
| 3. | Deep Track Capital David Kroin | 1,800,000 | $56,484,000 | +28% | 1.81% |
| 4. | Biotechnology Value Fund / BVF Inc Mark Lampert | 1,024,288 | $32,142,157 | 1.15% | |
| 5. | Kynam Capital Derrick Tang | 976,267 | $30,635,258 | -43% | 3.3% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.56 | 92,349 | $2,729,864.14 | 2,144,060 | 2025-03-17 | Filing | |
| $29.56 | 8,589 | $253,893.42 | 178,596 | 2025-03-17 | Filing | |
| $29.74 | 646,290 | $19,221,698.66 | 2,051,711 | 2025-03-17 | Filing | |
| $29.74 | 60,110 | $1,787,767.58 | 170,007 | 2025-03-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $35.23 | 61,849 | $2,178,940.27 | 0 | 2025-09-30 | Filing | |
| $35.01 | 200 | $7,002.00 | 0 | 2025-09-15 | Filing | |
| $36.31 | 1,300 | $47,203.00 | 0 | 2025-09-12 | Filing | |
| $35.63 | 21,232 | $756,496.16 | 1,300 | 2025-09-12 | Filing | |
| $36.28 | 19,081 | $692,258.68 | 0 | 2025-09-11 | Filing |
Institutional Investors' Holdings
News See All
Immunocore Holdings plc (NASDAQ:IMCR) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Immunocore Holdings plc conference call and webcast. At this time, all participants are in a listen-only mode.
10 Best Small-Cap Stocks Ready To Explode
On October 7, Chuck Royce, founder and Senior Advisor, and Francis Gannon, Co-Chief Investment Officer and Managing Director of Royce Investment, discussed the outperformance of small-cap stocks.
10 Best Immunotherapy Stocks to Buy Now
The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by 2033.
8 High Growth UK Stocks to Invest In
According to a KPMG report, the United Kingdom’s GDP growth is projected to slow in the second half of 2024 but is expected to rise slightly to 1.2% in 2025.
10 Worst Falling Stocks To Buy Now
To the new investor, the stock market can appear to be an unpredictable graph that has no inherent logic to its ups and downs.
15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers
The U.S. Federal Reserve conducting a 50 basis point interest rate cut was the catalyst that stocks needed to bounce back from a period of stagnation.
10 Worst Cancer Stocks To Buy Now According to Short Sellers
Cancer is the second leading cause of death globally, just behind cardiovascular disease, making oncology one of the largest sectors in the life sciences.
Top 10 ADR Stocks To Buy According to Hedge Funds
Diversifying an investment portfolio is one of the best ways of spreading risk and minimizing the impact of heightened volatility.
Immunocore Holdings plc (NASDAQ:IMCR) Q2 2024 Earnings Call Transcript
Operator: Welcome to the Immunocore Conference Call and Webcast. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.